STAT Plus: CureVac’s value soars after IPO, as Covid-19 vaccine manufacturers become biotech’s hottest companies
THOMAS KIENZLE/AFP VIA GETTY IMAGES
CureVac, headquartered in Germany, saw its share price nearly triple within hours of an initial public offering on Friday.


No hay comentarios:
Publicar un comentario